Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients

Published:2017-11-15 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Jin,Zhang Xiaonan,Chen Liang,Zhang Zhanqing,Zhang Jiming,Wang Weixia,Wu Min,Shi Bisheng,Zhang Xinxin,Kozlowski Maya,Hu Yunwen,Yuan Zhenghong

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-15594-0.pdf

Reference34 articles.

1. Dienstag, J. L. Hepatitis B virus infection. N Engl J Med 359, 1486–1500, https://doi.org/10.1056/NEJMra0801644 (2008).

2. Mohamed, R. et al. Knowledge, attitudes and practices among people with chronic hepatitis B attending a hepatology clinic in Malaysia: a cross sectional study. BMC Public Health 12, 601, https://doi.org/10.1186/1471-2458-12-601 (2012).

3. Lau, G. K. et al. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352, 2682–2695, https://doi.org/10.1056/NEJMoa043470 (2005).

4. Janssen, H. L. et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365, 123–129, https://doi.org/10.1016/s0140-6736(05)17701-0 (2005).

5. Liaw, Y. F. Impact of therapy on the long-term outcome of chronic hepatitis B. Clin Liver Dis 17, 413–423, https://doi.org/10.1016/j.cld.2013.05.005 (2013).

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of monocyte activity by hepatocellular MicroRNA delivery through HBsAg particles: Implications for pathobiology of chronic hepatitis B;Hepatology;2024-06-20

2. The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection;Microorganisms;2023-11-08

3. Liver Damage and microRNAs: An Update;Current Issues in Molecular Biology;2022-12-23

4. Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B;Journal of Clinical and Translational Hepatology;2022-05-13

5. Significance of T-Cell Subsets for Clinical Response to Peginterferon Alfa-2a Therapy in HBeAg-Positive Chronic Hepatitis B Patients;International Journal of General Medicine;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3